drugset / Trial / NCT06453551
A Phase I Study of TRN501 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of TRN501 following a single administration of TRN501 or placebo to healthy adult male volunteers.
Timeline
- Start
- 2024-05-10
- Primary completion
- 2024-09-20
- Completion
- 2024-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TRN501 | Unknown | — | — |